Complications of Feeding Jejunostomy Tubes in Patients with Gastroesophageal Cancer
Feeding jejunostomy tubes (FJT) in patients undergoing resection of gastroesophageal cancers facilitate perioperative nutrition. Data regarding FJT use and complications are limited.
A single institution review was performed for patients who underwent perioperative FJT placement for gastrectomy or esophagogastrectomy from 2007 to 2015. FJT-related and unrelated complications were evaluated.
FJTs were inserted for total/completion gastrectomy (n = 49/117, 41.9 %), proximal gastrectomy (n = 7/117, 6.0 %), or esophagogastrectomy (n = 61/117, 52.1 %). Ninety percent (n = 106/117) of patients used an FJT at some time point. Although the majority of patients (75.2 %) used FJTs after discharge, 8.5 % (n = 10/117) never used the FJT and 10.3 % (n = 12/117) used the FJT only during hospitalization. Overall, 44.4 % (n = 52/117) had FJT-related complications, including dislodgement (n = 22), clogging (n = 13), and leakage (n = 6). The majority of FJT complications were resolved by telephone triage (13.5 %) or bedside/clinic intervention (57.7 %), but 3.4 % required operative intervention for small bowel obstruction (n = 3) and hemorrhage (n = 1). FJT complications were more common with gastrectomy than esophagogastrectomy (53.6 vs. 36.0 %), perhaps related to longer FJT use in gastrectomy patients (71 vs. 38 days).
FJT-related complications are common, occurring more frequently after gastrectomy than esophagogastrectomy. In most patients, complications can be managed by simple measures, rarely requiring operative intervention. Nevertheless, the need for FJTs should be carefully considered to balance nutritional benefits with the risks of insertion and usage.
KeywordsJejunostomy tube Gastric cancer Esophageal cancer Outcomes Complications
Dr. Chao’s efforts in manuscript preparation were supported by the National Cancer Institute of the National Institutes of Health under award number NIH 5K12CA001727-20. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
JYK and JK contributed to the conception/design of the work; AHC and MPO contributed to the acquisition of data; SJM, VS, JC, and DJR contributed to the analysis/interpretation of data; AHC and MPO drafted the manuscript; all authors critically revised the manuscript for intellectual content; all authors approved the final version submitted and agreed to be accountable for all aspects of the work.
Compliance with Ethical Standards
- 1.NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Gastric Cancer, version 3.2015. National Comprehensive Cancer Network 2015 February 20, 2016]; Available from: http://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf.
- 2.NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Esophageal and Esophagogastric Junction Cancer, version 3.2015. National Comprehensive Cancer Network 2015 February 20, 2016]; Available from: http://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf.
- 5.Dann, G.C., et al., An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the U.S. gastric cancer collaborative. J Surg Oncol, 2015. 112(2): p.195–202.Google Scholar
- 6.Sun, Z., Shenoi, M.M., Nussbaum D.P., et al., Feeding jejunostomy tube placement during resection of gastric cancers. J Surg Res, 2016. 200(1): p. 189–94.Google Scholar
- 10.Swails W.S., B.T.J., Ellis F.H., Kenler A.S., Forse R.A., The role of enteral jejunostomy feeding after esophagogastrectomy: a prospective, randomized study. Dis Esophagus, 1985. 8: p. 193–199.Google Scholar